Sourasky Medical Center (Ichilov)
| イスラエル | トルコ | オーストリア | |
| 白血病化学療法 | から $28,500 | から $8,000 | から $15,000 |
オフェル・メリムスキー教授は、骨腫瘍・軟部腫瘍・中皮腫・肺癌・肝臓および肺への転移性病変を専門とする著名な腫瘍内科医です。スラスキー医療センター（イヒロフ、テルアビブ）の骨格・軟部腫瘍科の科長を務め、イスラエル臨床腫瘍医協会の会長を兼任しています。
主な専門領域と患者様へのメリット：
患者様はメリムスキー教授の深い腫瘍学的知識、個別化された治療計画の立案能力、そして細やかな対応を高く評価しており、治療の全過程を通じて安心感と信頼感が得られると好評です。
Israel leads in leukemia treatment with board-certified hematologists who pioneer molecular diagnostics and gene therapy. These specialists practice at JCI-accredited centers like Sourasky and Hadassah. They offer advanced chemotherapy and stem cell transplants. Many received elite training at Memorial Sloan-Kettering and Stanford University.
Bookimed Expert Insight: Coordination data shows that top Israeli hematologists often hold dual roles as department heads and active researchers. For example, Dr. Ofer Merimsky and Dr. Ronit El Hasid at Sourasky Medical Center provide direct access to protocols usually found in clinical trials. Patients can also book video consultations with these experts, with fees ranging from $950 to $1050.
Patient Consensus: Patients note that major Israeli medical centers provide clear treatment protocols and fast appointment scheduling. They appreciate that senior doctors like Dr. Michael Shapira are fluent in English. International families often emphasize the professional organization when coordinating complex transplants for children.
Top pediatric leukemia specialists in Israel include board-certified experts at JCI-accredited centers like Sourasky and Assuta. These leaders specialize in complex bone marrow transplants and advanced chemotherapy. Many hold fellowships from premier US institutes like Memorial Sloan-Kettering and City of Hope Hospital.
Bookimed Expert Insight: Data shows a high concentration of specialists with international backgrounds in Tel Aviv. For example, Dr. Ofer Merimsky and Dr. Ronit El Hasid bring specialized fellowship experience from Paris and Los Angeles. This exposure allows them to implement diverse chemotherapy protocols often unavailable in standard regional hospitals.
Patient Consensus: Parents note that children often reach remission within weeks using tailored protocols after previous treatments failed. They frequently mention the relief of findng English-speaking staff and supportive family lodging during long stays. Many families also appreciate starting with video consultations to avoid travel delays.
Israel leads in CAR T-cell therapy through specialized hematologists and early adoption of cellular protocols. Top experts like Dr. Herishanu Yair and Prof. Arnon Nagler deliver these advanced immunotherapies at JCI-accredited centers. These specialists focus on refractory leukemia using FDA-approved and in-house developed cell products.
Bookimed Expert Insight: Data shows that choosing specialists at larger academic centers like Sourasky or Hadassah provides faster access to varied cell lines. For instance, Dr. Ofer Merimsky offers consultations for $950, which often includes a comprehensive review of eligibility for advanced trials. These institutions frequently run parallel tracks for both commercial and experimental CAR-T protocols.
Patient Consensus: Patients note that pediatric programs often provide faster access to CAR-T for children and teenagers. Families emphasize the importance of having bridging chemotherapy ready to remain eligible for the procedure. Many were surprised by the intensive monitoring required for neurotoxicity but felt reassured by the rapid medical response.
Israeli hematologists maintain standards equivalent to US doctors through rigorous medical training and international fellowships. Many specialists hold certifications from the American Society of Hematology. They often train at elite institutions like Memorial Sloan-Kettering and Stanford University to master advanced leukemia protocols.
Bookimed Expert Insight: Data shows that Israeli hematology leadership is defined by long-term clinical continuity at top centers. For example, Dr. Arnon Nagler at Sheba Medical Center has 35+ years of experience and pioneered the nation's first public cord blood bank. This deep local expertise, combined with training from US institutions like Stanford, ensures patients receive globally recognized care in Tel Aviv and Jerusalem.
Patient Consensus: Patients note that Israeli hospitals often provide faster diagnostic turnaround times for urgent leukemia cases compared to the US. They also feel reassured that the chemotherapy protocols follow the exact same international NCCN and ESMO guidelines used in American clinics.
Most senior hematologists in Israel speak fluent English because they complete fellowships at top American and European hospitals. Many leading specialists such as Professor Michael Shapira at Sourasky Medical Center (Ichilov) specifically provide English-language care for international patients seeking complex leukemia chemotherapy.
Bookimed Expert Insight: Data shows that senior department heads at clinics like Sourasky or Sheba almost always have extensive North American training. For example, Dr. Ron Ram completed his fellowship at New York Medical College. This pattern ensures that patients receive explanations in familiar medical English, which is vital for understanding complex protocols like stem cell transplants.
Patient Consensus: Patients note that while some administrative staff might only speak Hebrew, the doctors and senior specialists are highly fluent in English. They emphasize the importance of requesting an international coordinator to ensure smooth communication during long-term chemotherapy treatments.
Yes, you can secure an online consultation with top Israeli leukemia specialists through Bookimed. Expert hematologists provide remote second opinions and treatment plan reviews via video calls. Most leading doctors hold American or European board certifications and have trained at centers like Memorial Sloan-Kettering.
Bookimed Expert Insight: Analysis of specialist profiles reveals that top Israeli hematologists offer unique international expertise. For instance, Dr. Ofer Merimsky at Sourasky Medical Center provides consultations for $950, reflecting deep specialization in rare sarcoma-related leukemias. Patients can also access specialists with 30+ years of experience, such as Dr. Fredi Aviv, who handles both adult and pediatric cases at JCI-accredited facilities.
Patient Consensus: Patients value the professionalism and ease of organizing video calls with renowned professors. Many note that having a clear connection to a specialist helps clarify their diagnosis before travel. They often feel more confident after discussing advanced targeted therapies with doctors who speak fluent English.